R&D | December 08, 2025
B Braun unveils ready-to-use antibiotic system
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Takeda will pay Innovent US$1.2 billion upfront, including a US$100 million equity investment in Innovent
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Growing patent filings and tier-2 innovators reflect expanding national research base
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
Subscribe To Our Newsletter & Stay Updated
